Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Help Therapeutics Raises $25 Million for iPSC Heart Failure/Oncology Therapies

publication date: Nov 29, 2021

Nanjing Help Therapeutics completed a $25 million Series C financing to develop its stem cell programs for heart failure and oncology immunotherapies. The company says its induced pluripotent stem cell (iPSC) technology offer a better alternative for cell therapies than current manual manufacturing systems. Help Therapeutics will use its iPSC technology to conduct heart cell injection trials and to start clinical trials of an immune cell therapy next year. The C round was led by Ming Bioventures and included Share Capital, Beisen Medical Fund, and Jolmo Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here